Dr. Immaculata De Vivo is Associate Professor of Medicine at Harvard Medical School/Brigham and Women’s Hospital and Associate Professor of Epidemiology at the Harvard School of Public Health. Dr. De Vivo is an international leader in the area of molecular and genetic epidemiology of cancer. Her research focuses on how the environment interacts with genetic variants to influence susceptibility to hormonal cancers. Her laboratory focuses primarily on the discovery and characterization of genetic biological markers to assess disease susceptibility in human populations. Dr. De Vivo is also a leader in the field of telomere biology. Her work has added tremendous insight to the role of telomeres in cancer etiology. Because telomere length has both genetic and environmental determinants she has also demonstrated how lifestyle choices can delay or accelerate telomere shortening. A specific example is her work with telomeres and adherence to the Mediterranean diet. Her finding that adherence to a Mediterranean diet, published in British Medical Journal, can delay telomere shortening was particularly notable for its broad implications that DNA can be modified by lifestyle choices. It was recognized by scientific community with an award in 2015 by the Universita Popolare Medicina degli Stili di Vita for her work exploring the molecular mechanism by which the Mediterranean diet improves longevity. It was also recognized by the lay community with extensive press coverage including CNN, NYT, Forbes. She is the Director of the Dana Farber/Harvard Cancer Center Genotyping and Genetics for Population Sciences Facility, the co-leader of the National Cancer Institute supported Epidemiology of Endometrial Cancer Consortium (E2C2) and the Editor-In-Chief of the internationally recognized journal Cancer Causes and Control.